![Caroline Quay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Quay
Directeur/Membre du Conseil chez
Caramed Capital Ltd.
Profil
Caroline Quay is the founder and the Managing Partner at MQB Partners Ltd, a firm founded in 2023.
She is currently the Director & Managing Partner at Caramed Capital Ltd. since 2020 and the Principal at Catalyst Investments LP (Management) since 2015.
Ms. Quay has previously worked as the Director at Objective Acuity Ltd. from 2017 to 2018, the General Counsel at Fisher & Paykel Healthcare Corp.
Ltd. from 2003 to 2015, the General Counsel at Aroa Biosurgery Ltd. from 2015 to 2021, and the Chief Investment Officer at Cure Kids Ventures Ltd. from 2017 to 2021.
She obtained her undergraduate degree from Auckland University in 1996.
Postes actifs de Caroline Quay
| Sociétés | Poste | Début |
|---|---|---|
Catalyst Investments LP (Management)
 Catalyst Investments LP (Management) Investment ManagersFinance Catalyst is an active manager which invests in companies located in the United States, Europe and China. The firm targets companies operating in the fields of various technology sectors. It provides financing for later stage and growth capital requirements and it takes a seat on the board of directors. | Private Equity Investor | 01/02/2015 |
Caramed Capital Ltd. | Directeur/Membre du Conseil | 01/10/2020 |
Anciens postes connus de Caroline Quay
| Sociétés | Poste | Fin |
|---|---|---|
Cure Kids Ventures Ltd.
 Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures invests in companies located in New Zealand. The firm focuses on medical devices, medications, diagnostics, health information and healthcare delivery system sectors. It provides financing for seed and early stage capital requirements. | Directeur en chef des Investissements | 01/12/2021 |
| AROA BIOSURGERY LIMITED | Conseiller Juridique Général | 01/01/2021 |
Objective Acuity Ltd.
 Objective Acuity Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops vision testing equipment to detect visual function | Directeur/Membre du Conseil | 01/11/2018 |
| FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | Conseiller Juridique Général | 01/01/2015 |
Formation de Caroline Quay
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Fisher & Paykel Healthcare Corp. Ltd.
 Fisher & Paykel Healthcare Corp. Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and markets healthcare devices | Health Technology |
Auckland University
 Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalyst Investments LP (Management)
Catalyst Investments LP (Management) Investment ManagersFinance Catalyst is an active manager which invests in companies located in the United States, Europe and China. The firm targets companies operating in the fields of various technology sectors. It provides financing for later stage and growth capital requirements and it takes a seat on the board of directors. | Finance |
Aroa Biosurgery Ltd.
 Aroa Biosurgery Ltd. Medical SpecialtiesHealth Technology Develops medical devices for soft tissue regeneration and cellular scaffolding | Health Technology |
Cure Kids Ventures Ltd.
Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures invests in companies located in New Zealand. The firm focuses on medical devices, medications, diagnostics, health information and healthcare delivery system sectors. It provides financing for seed and early stage capital requirements. | Finance |
Objective Acuity Ltd.
Objective Acuity Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops vision testing equipment to detect visual function | Electronic Technology |
Caramed Capital Ltd. |
